Results 11 to 20 of about 1,027,648 (153)

Reshaping the cardiovascular continuum in the management of arterial and venous cardiovascular disease: a narrative review [PDF]

Journal of Comparative Effectiveness Research
The prevalence of cardiovascular disease (CVaD) is expected to double in the next 25 years, fueled by increasing prevalence of diabetes mellitus, obesity and hypertension.
Khadija Hafidh, Melina Vega de Ceniga, Leonardo De Luca, Claudio Borghi   +3 more
doaj   +2 more sources

Case Report: Micronized purified flavonoid fraction [Daflon]-induced bradycardia [PDF]

Frontiers in Pharmacology
IntroductionFlavonoids are oral venoactive drugs frequently prescribed to relieve the symptoms of chronic venous disorders. Micronized purified flavonoid fraction (MPFF, commercial Daflon 1000 mg) is a preparation that contains mainly diosmin and a small
Jhennyfer Aline Lima Rodrigues, Jonathas Pereira das Graças, Gledson de Oliveira Machado   +2 more
doaj   +2 more sources

An international observational study assessing conservative management in hemorrhoidal disease: results of CHORALIS (aCute HemORrhoidal disease evALuation International Study) [PDF]

Journal of Comparative Effectiveness Research
Aim: Real-world evidence on the management of hemorrhoidal disease (HD) is limited. This international study collected clinical practice data on the effectiveness of conservative treatments for acute HD on symptoms and quality of life (QoL), providing ...
Philippe Godeberge, Zoltan Csiki, Mykhailo Zakharash, Elly Nyaim Opot, Yuri A Shelygin, Trung Tin Nguyen, Ashraf Amir, Ibrahima Konate, Moses Momoh, Joanna Chirol, Vanessa Blanc-Guillemaud, Ren Donglin   +11 more
doaj   +2 more sources

Improving Hemorrhoid Outcomes: A Narrative Review and Best Practices Guide for Pharmacists [PDF]

Pharmacy
Hemorrhoidal disease remains a prevalent yet often overlooked condition, affecting millions worldwide and imposing a substantial healthcare burden. Despite the availability of multiple treatment options, gaps persist in patient education, early symptom ...
Nardine Nakhla, Ashok Hospattankar, Kamran Siddiqui, Mary Barna Bridgeman   +3 more
doaj   +2 more sources

A Response to: Letter to the Editor Regarding "Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs". [PDF]

Adv Ther
Gianesini S.
europepmc   +3 more sources

The role of venoactive compounds in the treatment of chronic venous disease. [PDF]

J Vasc Surg Venous Lymphat Disord
Gloviczki ML, Kakkos SK, Urbanek T, Chuback J, Nicolaides A.   +4 more
europepmc   +2 more sources

Delphi Consensus on the Role of Venoactive Nutraceuticals in the Management of Chronic Venous Disease: A Position Statement of the Italian Society of Angiology and Vascular Medicine (SIAPAV). [PDF]

Nutrients
Buso G, Santini P, Ghirardini F, Bigolin P, Martini R, On Behalf Of The Siapav Working Group On Venoactive Nutraceuticals.   +5 more
europepmc   +2 more sources

The potential use of flavonoids as venoactive drugs and the role of citrus fruits

Journal of Intercultural Ethnopharmacology, 2018
Sergei V. Jargin
exaly   +4 more sources

Current indications for phlebotropic therapy and its duration

Амбулаторная хирургия, 2021
Phlebotropic therapy is an important component of the pathogenetic treatment of chronic venous insufficiency (CVI) of the lower extremities. Venoactive drugs, which have proven their effectiveness and safety in a variety of studies, are widely ...
V. Yu. Bogachev, B. V. Boldin, P. Yu. Turkin, O. V. Dzhenina, A. Yu. Samenkov   +4 more
doaj   +1 more source

Diosmin or Hesperidin? Comparison of Antioxidative Action of Two Venoactive Flavonoids in Type 1 Diabetic Rats. [PDF]

Int J Mol Sci
Borymska W, Borymski S, Zych M, Dudek S, Kaczmarczyk-Żebrowska I.   +4 more
europepmc   +2 more sources